To investigate the function of a basic and neutral amino acid transporter-like protein (rBAT) which is a candidate gene for cystinuria, we analysed the rBAT gene in cystinuric patients. Patient 1 is a compound heterozygote with mutations in the rBAT gene causing a glutamine-to-lysine transition at amino acid 268, and a threonine-to-alanine transition at amino acid 341, who inherited these alleles from his mother (E268K) and father (T341A), respectively. Injection of T341A and E268K mutant cRNAs into oocytes decreased transport activity to 53.9 % and 62.5 % of control (L-cystine transport activity in oocytes injected with wild-type rBAT cRNA), respectively. Co-injection of E268K
INTRODUCTION
Amino acids are transported across the plasma membrane of cells via sodium-independent and sodium-dependent carriers [1] . Recently, cDNAs from rabbit and rat kidney cortex [named rBAT (b°+, amino acid transporter-related protein) and D2] have been cloned. Injection of rBAT or D2 into oocytes induces system b°' +, a sodium-independent carrier for cationic and neutral amino acids (including L-cystine) [2] [3] [4] . Cystinuria is an autosomal recessive disorder characterized by excessive urinary excretion of cystine and the basic amino acids [5] . The major clinical manifestation of the disease is the development of cystine kidney stones resulting from the low solubility of cystine in urine, leading to obstruction, recurrent infections and ultimately renal insufficiency [5] . Cystinuria is thought to result from defective transport ofcystine and dibasic amino acids through the epithelial cells of the renal tubules and intestinal tract [5] . Recently, Palacin and co-workers have identified six specific mutations in the rBAT gene, including homozygotes and compound heterozygotes, that segregate with the cystinuria phenotype [6] . These mutations nearly abolish the amino acid transport activity induced by rBAT in Xenopus oocytes [6] . The rBAT protein contains seven potential N-glycosylation sites near its putative extracellular C-terminus [2] [3] [4] . The presence of a leucine zipper motif at a C-terminus raises the possibility that the protein is associated with a second subunit [7] . The mutations found in patients with cystinuria are located in this C-terminal region of the rBAT protein [6] . However, it is still unclear how these mutations in the rBAT protein abolish amino acid transport activity. The predicted structure of the rBAT protein is not very [8] .
PCR product sequencing PCR amplification products were subcloned into pBluescript II KS' (Stratagene) and sequenced by the chain termination method using T7 DNA polymerase (Pharmacia). No less than six clones were sequenced to ensure against Taq polymerase artifacts and to determine the sequence of both alleles.
cDNA cloning
Human rBAT clones were isolated from a human kidney library in phage AgT-10 [10, 11] . A 32P-labelled probe (rabbit rBAT cDNA) was prepared from a PCR fragment. Three clones were subcloned into pBluescript II and sequenced, the human rBAT
Site-directed mutagenesis and in vitro transcription
We constructed a plasmid containing the complete human rBAT cDNA in pBluescript II as a template for E268K and T341A mutant rBAT construction by site-directed mutagenesis. The mutagenesis primers (anti-sense strand) were 5'-TGGCACTTT-GACAAAGTGCGAAC-3' (E268K) and 5'-CCGGACACGG-TCGCACAATACTCG-3' (T341A) respectively. rBAT mutagenesis was performed as previously described [9] . rBAT cDNA clones were linearized by digestion with Xhol and transcribed into rBAT complementary RNA (cRNA) using T3 RNA polymerase (Promega) [10] .
Oocyte injections and transport assay
Xenopus laevis females were obtained from Hamamatsu Jikkenn (Sizuoka, Japan). Small clumps of oocytes were treated twice for 90 min with collagenase at 2 mg/ml in a Ca2+-free solution (ORII solution: 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 10 mM Hepes/ Tris, pH 7.5) to remove the follicular layer [9, 10] . Six patients with cystinuria were screened for mutations in the rBAT coding region by SSCP analysis. PCR primers were designed with allowed amplification of overlapping cDNA products encompassing the entire rBAT coding region of 685 amino acids (Figure 1 ). cDNAs from each cystinuria patient were analysed by SSCP for each of the seven overlapping PCR products. The corresponding PCR products were sequenced to determine the nature of each variation in SSCP. New PCR primers were then designed around each of the sequence alterations that allowed PCR amplification and sequence conformation analysis using genomic DNA as a template. Two missense point mutations of rBAT were found in genomic DNA from patient 1. Two other polymorphisms, G204A and A198T, were detected in two other cystinuria patients. To verify that these substitutions were not due to PCR artifacts, direct sequencing of the amplification fragments was performed, which confirmed these transitions. Sequence analysis demonstrated that patient 1 was a compound heterozygote at the rBAT locus with a guanidine-toadenine change at nt 802, changing the glutamine 268 residue to lysine (E268K) and an adenine-to-guanidine change at nt 1021 changing the threonine 342 residue to alanine (T341A). He has inherited the allele E268K from his mother and T341A from his father (Figure 2) .
Characterization of the E268K and T341A mutants
To study the effect of the E268K and T341A changes on the L-arginine and L-cystine transport activity induced by human rBAT, corresponding substitutions were introduced into the rBAT cDNA by PCR-primer-directed mutagenesis and three rBAT cRNA were expressed and injected into Xenopus oocytes: a wild-type cRNA (rBAT-WT) and mutants carrying either the E268K or T341A mutations. cRNA were synthesized and injected into Xenopus oocytes, and the uptake of [35S]cystine and [3H]arginine were determined. Wild-type rBAT injection into oocytes resulted in the induction of system b°+-like amino acid transport; this system is responsible for sodium-independent uptake of L-arginine and L-cystine. Wild-type rBAT significantly stimulated the uptake of these two amino acids, as previously Two mis-sense point mutations of rBAT were found in genomic DNA from patient 1. Sequence analysis indicated that the mutation was present in a compound heterozygote with a G to A transition at nt 802, changing E to K at amino acid 268, and an A to G transition at nt 1021, changing T to A at amino acid 341. He has inherited these alleles from his mother (E268K) and father (T341A) respectively. reported by several groups [2] [3] [4] . For comparison, the relative residual activities in Xenopus oocytes injected with cRNA are shown in Table 1 . The L-cystine uptake activity in oocytes injected with T341A and E268K rBAT cRNAs were significantly lower (53.9 + 5.8 % and 62.5 + 13.3 % of control, respectively) than the activity in wild-type rBAT-injected oocytes. The relative L-arginine transport activity in oocytes injected with E268K or T341A mutant rBAT was similarly decreased. No significant difference was found between the relative amino acid uptake in G204A and A198T rBAT cRNA mutants and wild-type rBAT cRNA-injected oocytes (results not shown).
We also determined the kinetics of L-cystine uptake in oocytes injected with each mutant rBAT. Uptake of L-cystine, as shown on a Michaelis-Menten plot, was saturable ( Figure 3) were incubated for 24 h at 18°C in 0.5 ml of modified Barth's solution. Oocytes were then harvested and used for immunoprecipitation experiments as described in the Materials and methods section.
1, because oocytes injected with the mutant rBAT cRNA still had about 50 % amino acid transport activity. To address this question, we co-injected a two-mutant cRNA mixture into Xenopus oocytes. As shown in Table 2 , co-injection of E268K and T341A cRNA mutants strongly decreased amino acid transport activity compared with wild-type rBAT-injected oocytes. These results indicate that mutations in the rBAT gene are crucial disease-causing lesions in cystinuria.
To rule out the possibility that the reduction of transport activities in mutant rBAT-injected oocytes was caused by reduced rBAT synthesis or insertion into the cell membrane, oocytes were radiolabelled and rBAT levels analysed by immunoprecipitation with anti-rBAT antibody. As shown in Figure 4 , radiolabelled rBAT was present at similar levels in oocytes injected with wildtype and mutant cRNAs. As expected, rBAT was barely de- 
DISCUSSION
In this study, we have characterized a novel mutant allele that is associated with cystinuria in a Japanese patient. Amino acid residues 341T and 268E are highly conserved in human, rat and rabbit rBAT [2] [3] [4] . Recently, Tate and co-workers have demonstrated that rBAT has four transmembrane domains using sitedirected polyclonal antibodies directed against rBAT [14] . This proposed structure is distinct from that of other known mammalian transporters which, in general, are more complex proteins presumed to contain from 8 to 14 transmembrane domains [14] . E268K and T341A are present in the first transcellular loop. Our results suggest that these mutations significantly affect the function of rBAT as an amino acid transporter. Interestingly, we also found that co-injection of both rBAT mutants (T341A and E268K) into oocytes strongly reduced amino acid uptake. These results indicate that T341A and E268K substitutions may be crucial disease-causing mutations in cystinuria.
In amino acid excretion values in urine of the family members, the mother (bearing the E268K mutation) has normal urinary cystine levels. This is in contrast to the father (bearing the T341A mutation) and the child. Both mutations, however, cause a similar reduction in transport levels. In contrast, the mother has high urinary lysine levels. This may be due to a complex transport pathway for L-cystine in renal membranes [1] . Studies with brush-border-membrane vesicles indicate two transport systems for L-cystine, suggesting the existence in renal membranes of a high-affinity system which is shared with dibasic amino acids, and a low-affinity system which appears to be unshared [1] .
Biochemical and immunological experiments have identified the b°I co-transporter as a polypeptide of90 kDa on SDS/PAGE reducing gels [12] , and about 78 kDa in vitro translation studies [15] . However, information regarding the structure-function relationships of rBAT in situ in the native membrane is lacking. In the case of the Nae-dependent glucose transporter, which contains multiple membrane-spanning regions, a high-energy electron radiation inactivation method indicated that this transporter functions in the membrane as a homotetramer composed of four independent subunits [16] . Similar studies on rBAT are now in progress. On the other hand, the potential for association of rBAT with other proteins is indicated by the presence of a leucine zipper motif and a conserved cystine residue at the external membrane interface [7] . We have confirmed the importance of interaction with other proteins at the external membrane interface, because a point mutation (L565P) in the leucine zipper motif of rBAT significantly decreased the uptake of L-arginine (K. Miyamoto, unpublished work mentioned above, the C-terminal region (511-685) of rBAT is important for interactions with other proteins and for determining its specificity as a transport activator. Furthermore, we could not find any rBAT mutations in other Japanese cystinuria patients. These observations suggest that mutations in other components of the amino acid transport system may cause cystinuria. Alternatively, the wild-type rBAT stimulated a b°+ system with broad substrate specificities for cystine and for basics and some neutral amino acids. If rBAT functions as an activator for an amino acid transport system, multiple rBAT subunits may interact with transporter proteins, because of the low transport activity in oocytes co-injected with rBAT mutants compared with those injected with each rBAT mutant alone.
In voltage-and current-clamp studies, Busch et al. have suggested that the system induced by rBAT is an amino acid exchanger [17] . rBAT-mediated transport of neutral and dibasic amino acids is associated with net outward or inward currents, respectively, which may be caused by an exchange of neutral with dibasic amino acids. However, it is not clear how an exchanger can perform its function in proximal renal tubular and intestinal amino acid absorption, because, in these epithelial cells, Na+-coupled transport systems allow the cellular accumulation of neutral amino acids [17] . Thus the function of rBAT in amino acid transport is still unknown. Present studies indicate that rBAT is a candidate gene for cystinuria, and a loss of rBAT function could decrease the activity of the cystine transport system. Further studies are still needed to clarify the molecular basis of cystinuria.
